Table 1.
Cohort characteristics of patient samples included in this study. All patients were triaged to a gynecological oncology specialist centre for secondary evaluation and surgery.
| All | Pre-Menopausal | Post-Menopausal | ||
|---|---|---|---|---|
| # Participants (Total) | n = 169 | n = 66 | n = 103 | |
| Age at diagnosis (years) | median | 54 | 44.6 | 62.6 |
| IQ range | 47–65 | 40–49 | 56–69 | |
| Pathology (n=) | benign | 113 | 57 | 56 |
| malignant | 56 | 9 | 47 | |
| Tumour type (n=) | Serous | 44 | 4 | 40 |
| endometroid | 4 | 1 | 3 | |
| clear cell | 3 | 2 | 1 | |
| mixed epithelial | 5 | 2 | 3 | |
| Grade (n=) | 1 | 2 | 1 | 1 |
| 2 | 5 | 1 | 4 | |
| 3 | 49 | 7 | 42 | |
| Stage (n=) | I | 7 | 4 | 3 |
| II | 3 | nil | 3 | |
| III–IV | 46 | 5 | 41 | |
| Genetic Predisposition (n=) | BRCA1 | 29 | 16 | 13 |
| BRCA2 | 33 | 17 | 16 | |
| other (lynch, BRIP1+, PALB+, VUS) | 18 | 10 | 8 | |
| wild type | 19 | 7 | 12 | |
| unknown | 70 | 16 | 54 | |
| Ultrasound score (n=) | 1 | 101 | 50 | 51 |
| 4 | 68 | 16 | 52 | |